Electrophysiology Mapping and Ablation Devices Market
According to Intent Market Research, the Electrophysiology Mapping and Ablation Devices Market is expected to grow from USD 7.9 billion in 2023 at a CAGR of 8.3% to touch USD 13.8 billion by 2030. The Electrophysiology Mapping and Ablation Devices Market is dominated by key players such as Medtronic PLC, Abbott Laboratories, Johnson & Johnson (Biosense Webster), Boston Scientific Corporation, Philips Healthcare, Siemens Healthineers, MicroPort Scientific Corporation, GE Healthcare, Stryker Corporation, AtriCure, Inc., ConMed Corporation, Hologic Inc., Invivo Corporation.